Skip to main content
. 2023 Jul 17;81:132. doi: 10.1186/s13690-023-01140-0

Table 1.

Long COVID distribution according to demography surveyed on 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh

Variables Sub-category ALL
(N = 2507)
No long COVID symptoms (N = 1944) Long COVID
(N = 563)
Mild
(N = 220; 0.08 [0.07-0.09]
Moderate
(N = 198; 0.07 [0.06-0.09]
Severe
(N = 145; 0.05 [0.04-0.06]
P
Age a Mean ± SD 37 ± 13.9 37 ± 14 37.2 ± 13.7 37.5 ± 13.7 36.8 ± 13.3 37.4 ± 14.5 0.930
Gender b Male 1530 (61%) 1183 (61%) 347 (62%) 145 0.05 [0.04-0.06] 118 0.04 [0.03-0.05] 83 0.03 [0.02-0.04] 0.223
Female 977 (39%) 761 (39%) 216 (38%) 75 0.02 [0.02-0.03] 80 0.03 [0.02-0.03] 62 0.02 [0.01-0.03]
Hospitalization b Hospitalized 280 (11.17%) 217 (11.16%) 63 (11.20%) 26 0.01 [0.00-0.01] 22 0.008 [0.00-0.01] 15 0.006 [0.00-0.009] 0.0001***
At least one COVID case in community b Yes 1615 (64%) 1284 (66%) 331 (59%) 119 0.04 [0.03-0.05] 113 0.04 [0.03-0.05] 98 0.03 [0.03-0.04] 0.0001***
At least one COVID case in family b Yes 1100 (44%) 871 (45%) 229 (41%) 88 0.03 [0.02-0.04] 83 0.03 [0.02-0.04] 58 0.02 [0.01-0.02] 0.0001***
Vaccination b Non-Vaccinated 109 (6%) 87 (4%) 22 (4%) 9 0.003 [0.00-0.006] 9 0.003 [0.00-0.006] 4 0.001 [0.00-0.004] 0.0001***
1st dose 259 (13%) 196 (10%) 63 (11%) 22 0.008 [0.00-0.01] 20 0.008 [0.00-0.01] 21 0.008 [0.00-0.01]
2nd dose 1589 (82%) 1256 (65%) 333 (59%) 124 0.04 [0.04-0.05] 125 0.04 [0.04-0.05] 84 0.03 [0.02-0.04]
Booster dose 550 (28%) 405 (21%) 145 (26%) 43 0.01 [0.01-0.02] 65 0.02 [0.02-0.03] 36 0.01 [0.01-0.02]
Living area b Urban 228 (9%) 168 (9%) 60 (11%) 29 0.01 [0.00-0.01] 18 0.007 [0.00-0.01] 13 0.005 [0.00-0.008] 0.324
Rural 848 (34%) 651 (33%) 197 (35%) 93 0.03 [0.03-0.04] 62 0.02 [0.01-0.03] 42 0.01 [0.01-0.02]
Semi urban 1431 (57%) 1125 (58%) 306 (54%) 97 0.03 [0.03-0.04] 118 0.04 [0.03-0.05] 90 0.03 [0.02-0.04]
Attending Rehabilitation b Yes 237 (9%) 8 (0.4%) 229 (41%) 52 0.02 [0.01-0.02] 100 0.03 [0.03-0.04] 77 0.03 [0.02-0.03] 0.0001***

aOne-way ANOVA, bFriedman’s ANOVA among mild, moderate, and severe cases with significant values (P) as < 0.001***, < 0.01**, and < 0.05*